Search
for

    Glossary Primary Amenorrhea

    condition where menstruation hasn't started by age 15

    Primary Amenorrhea is a medical condition where a person with female reproductive organs has not started menstruating by the age of 15 or within five years of the onset of puberty. This can be due to various factors, including genetic abnormalities, hormonal imbalances, or structural issues with the reproductive organs.

    Related Terms

    Research

    5 / 1000+ results
      Primary Amenorrhea

      research Primary Amenorrhoea

      April 2024 in “International Journal of Advanced Multidisciplinary Research and Studies”
      This study outlines a multidisciplinary approach to investigate primary amenorrhea, emphasizing the necessity to consider medical history, physical examination, and potential hormonal or anatomical causes, and recommends early referral in cases of chromosomal abnormalities or persistent amenorrhea following the development of secondary sexual characteristics.
      An Unusual Cause of Primary Amenorrhea

      research An Unusual Cause of Primary Amenorrhea

      May 2021 in “Journal of the Endocrine Society”
      In this case report, an 18-year-old Vietnamese female with primary amenorrhea and normal female phenotype was most likely diagnosed with müllerian agenesis, highlighting its association with embryologic underdevelopment of the müllerian duct.
      A 14-Year-Old Female with Primary Amenorrhea

      research SUN-069 A 14 Year Old Female with Primary Amenorrhea

      April 2020 in “Journal of the Endocrine Society”
      This case report emphasizes the importance of early diagnosis of Swyer Syndrome in adolescents with slow pubertal progression and primary amenorrhea due to the high risk of germ cell cancers.

      research WRIST PAIN IN A GYMNAST WITH PRIMARY AMENORRHEA

      May 1999 in “Medicine & Science in Sports & Exercise”
      This case report discusses an elite female gymnast who experienced delayed menarche likely due to exercise-associated amenorrhea and diagnosed wrist conditions, recommending a treatment of reduced weight-bearing and dietary review.

    Community Join

    2 / 1000+ results

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

       133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.